GCG and type 1 diabetes mellitus: In clinical studies, DPP-4 inhibitors reduced the prandial insulin dose and its daily dosage [13, 37], inhibited glucagon secretion [13, 15], and decreased the blood glucose levels in patients with T1DM (2-hour postprandial and 24-hour AUCs) [37].